Neogenomics Stock Price Patterns
| NEO Stock | USD 12.41 0.10 0.81% |
Momentum 54
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.306 | EPS Estimate Next Quarter 0.0492 | EPS Estimate Current Year 0.096 | EPS Estimate Next Year 0.1846 | Wall Street Target Price 14.4286 |
Using NeoGenomics hype-based prediction, you can estimate the value of NeoGenomics from the perspective of NeoGenomics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards NeoGenomics using NeoGenomics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards NeoGenomics using crowd psychology based on the activity and movement of NeoGenomics' stock price.
NeoGenomics Short Interest
An investor who is long NeoGenomics may also wish to track short interest. As short interest increases, investors should be becoming more worried about NeoGenomics and may potentially protect profits, hedge NeoGenomics with its derivative instruments, or be ready for some potential downside.
200 Day MA 9.0059 | Short Percent 0.0862 | Short Ratio 4.41 | Shares Short Prior Month 7.9 M | 50 Day MA 12.1442 |
NeoGenomics Hype to Price Pattern
Investor biases related to NeoGenomics' public news can be used to forecast risks associated with an investment in NeoGenomics. The trend in average sentiment can be used to explain how an investor holding NeoGenomics can time the market purely based on public headlines and social activities around NeoGenomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of NeoGenomics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about NeoGenomics.
NeoGenomics Implied Volatility | 1.29 |
NeoGenomics' implied volatility exposes the market's sentiment of NeoGenomics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if NeoGenomics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that NeoGenomics stock will not fluctuate a lot when NeoGenomics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in NeoGenomics to buy its stock at a price that has no basis in reality. In that case, they are not buying NeoGenomics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NeoGenomics after-hype prediction price | USD 12.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current NeoGenomics contract
Based on the Rule 16, the options market is currently suggesting that NeoGenomics will have an average daily up or down price movement of about 0.0806% per day over the life of the 2026-03-20 option contract. With NeoGenomics trading at USD 12.41, that is roughly USD 0.01 . If you think that the market is fully incorporating NeoGenomics' daily price movement you should consider acquiring NeoGenomics options at the current volatility level of 1.29%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
NeoGenomics | Build AI portfolio with NeoGenomics Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NeoGenomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NeoGenomics After-Hype Price Density Analysis
As far as predicting the price of NeoGenomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NeoGenomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NeoGenomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NeoGenomics Estimiated After-Hype Price Volatility
In the context of predicting NeoGenomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NeoGenomics' historical news coverage. NeoGenomics' after-hype downside and upside margins for the prediction period are 9.87 and 14.85, respectively. We have considered NeoGenomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NeoGenomics is not too volatile at this time. Analysis and calculation of next after-hype price of NeoGenomics is based on 3 months time horizon.
NeoGenomics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as NeoGenomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NeoGenomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NeoGenomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 2.49 | 0.05 | 0.18 | 8 Events / Month | 2 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.41 | 12.36 | 0.40 |
|
NeoGenomics Hype Timeline
On the 3rd of February NeoGenomics is traded for 12.41. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of 0.18. NeoGenomics is forecasted to decline in value after the next headline, with the price expected to drop to 12.36. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -0.4%, whereas the daily expected return is now at 0.31%. The volatility of related hype on NeoGenomics is about 422.03%, with the expected price after the next announcement by competition of 12.59. About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.86. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NeoGenomics has Price/Earnings (P/E) ratio of 272.37. The entity recorded a loss per share of 0.91. The firm had not issued any dividends in recent years. NeoGenomics had 1:100 split on the 16th of April 2003. Considering the 90-day investment horizon the next forecasted press release will be in about 8 days. Check out NeoGenomics Basic Forecasting Models to cross-verify your projections.NeoGenomics Related Hype Analysis
Having access to credible news sources related to NeoGenomics' direct competition is more important than ever and may enhance your ability to predict NeoGenomics' future price movements. Getting to know how NeoGenomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NeoGenomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NVS | Novartis AG ADR | 1.58 | 7 per month | 0.77 | 0.20 | 2.59 | (2.06) | 6.07 | |
| PFE | Pfizer Inc | 0.25 | 8 per month | 1.14 | 0.1 | 2.24 | (2.24) | 7.97 | |
| SNY | Sanofi ADR | (0.06) | 7 per month | 0.00 | (0.14) | 1.87 | (2.19) | 5.92 |
NeoGenomics Additional Predictive Modules
Most predictive techniques to examine NeoGenomics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NeoGenomics using various technical indicators. When you analyze NeoGenomics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NeoGenomics Predictive Indicators
The successful prediction of NeoGenomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NeoGenomics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NeoGenomics based on analysis of NeoGenomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NeoGenomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NeoGenomics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 17.07 | 17.15 | 15.43 | 16.2 | Days Of Inventory On Hand | 25.41 | 26.35 | 23.72 | 17.74 |
Pair Trading with NeoGenomics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeoGenomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoGenomics will appreciate offsetting losses from the drop in the long position's value.Moving together with NeoGenomics Stock
Moving against NeoGenomics Stock
| 0.81 | ACET | Adicet Bio | PairCorr |
| 0.77 | ACHC | Acadia Healthcare | PairCorr |
| 0.72 | DVA | DaVita HealthCare | PairCorr |
| 0.72 | EHC | Encompass Health Corp | PairCorr |
| 0.71 | ATPC | Agape ATP | PairCorr |
| 0.59 | SGRY | Surgery Partners | PairCorr |
The ability to find closely correlated positions to NeoGenomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeoGenomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeoGenomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeoGenomics to buy it.
The correlation of NeoGenomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoGenomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoGenomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeoGenomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out NeoGenomics Basic Forecasting Models to cross-verify your projections. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Health Care Providers & Services sector continue expanding? Could NeoGenomics diversify its offerings? Factors like these will boost the valuation of NeoGenomics. Anticipated expansion of NeoGenomics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NeoGenomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.306 | Earnings Share (0.91) | Revenue Per Share | Quarterly Revenue Growth 0.119 | Return On Assets |
Investors evaluate NeoGenomics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating NeoGenomics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause NeoGenomics' market price to deviate significantly from intrinsic value.
It's important to distinguish between NeoGenomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NeoGenomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, NeoGenomics' market price signifies the transaction level at which participants voluntarily complete trades.